- Illumina’s Bid to Beat Cancer with DNA Tests
The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
- Hope in a Glove for Parkinson’s Patients
A wearable device promises to help steady hand tremors by using an old technology—gyroscopes.
- Parents Turn to Prozac to Treat Down Syndrome
The disorder known as trisomy 21 is untreatable. Or is it? Some families think an antidepressant could help.
- Big Pharma Doubles Down on CRISPR for New Drugs
A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body.
- RIP David Bowie, Internet Pioneer
Long before MySpace, the late rock star was focused on connecting with his fans online.
- In Pursuit of an Affordable Tablet for the Blind
By borrowing from microfluidics, a team of University of Michigan researchers are reinventing the Braille display to be cheaper and more useful.
- Advanced Nuclear Startup Terrestrial Energy Lands Initial Funding
Canadian startup pursuing an advanced molten-salt nuclear reactor gets significant outside backing. <
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.